MatriSys
is a California-based biopharmaceutical company that develops and commercializes microbiome therapeutics for the treatment of skin conditions... Read moreMatriSys
is a California-based biopharmaceutical company that develops and commercializes microbiome therapeutics for the treatment of skin conditions... Read more
News
Mar 20, 2023
StreetInsider
Press Release: MatriSys : MatriSys Bioscience Co-Founder Richard Gallo, MD, PhD Honored by AAD and AAAAI
Jan 04, 2023
PR Newswire
Press Release: MatriSys : MatriSys Bioscience Announces Corporate and Strategic Update
Jul 15, 2022
sec
MatriSys: MatriSys Received $8.4M in Equity Funding
Oct 21, 2021
GlobalNewswire
Press Release: MatriSys : MatriSys Announces Positive Results from a Study of S. felis for the Treatment of Drug-resistant S. pseudintermedius
Jul 29, 2021
Benzinga
MatriSys: MatriSys Bioscience to Present at the 4th Microbiome Movement Skin Health & Dermatology Summit
Mar 18, 2021
GlobeNewswire
Press Release: MatriSys : MatriSys Bioscience Expands Licensing Agreement with UCSD School of Medicine to Develop Acne Treatment
Mar 11, 2021
BioSpace
MatriSys: MatriSys Bioscience Raises more than $3 million to Advance its Portfolio of Products to Treat Inflammatory Skin DiseasesFunding will support MatriSys' growth and platform for its beneficial bacterial therapies
Feb 22, 2021
MarketScreener
MatriSys: MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis
Dec 01, 2020
EIN News
MatriSys: MatriSys Bioscience names Dr. Phillipe Calais as its New Chief Executive Officer and Member of its Board of Directors
Mar 20, 2019
4-traders
MatriSys Bioscience: MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment for Atopic Dermatitis
MatriSys Competitors
1
2
3
4
5
6
7
8
9
10